Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Multi-Dose Study to Evaluate the Safety and Efficacy of VDPHL01 in Male and Female Subjects With Androgenetic Alopecia

NCT06527365 is registered in ClinicalTrials.gov with Veradermics, Inc. as lead sponsor.

NCT NCT06527365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Multi-Dose Study to Evaluate the Safety and Efficacy of VDPHL01 in Male and Female Subjects With Androgenetic Alopecia
Lead sponsor
Veradermics, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 8, 2024
Completion date
August 31, 2026
Enrollment
70 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aga, androgenetic alopecia, male pattern baldness